Latest Breaking News On - Acadia pharmaceuticals inc - Page 4 : comparemela.com

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) to Post Q2 2024 Earnings of $0 09 Per Share, Leerink Partnrs Forecasts

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) to Post Q2 2024 Earnings of $0 09 Per Share, Leerink Partnrs Forecasts
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesMarkc schneyerRobertw bairdStephen davisLeerink partnrsMorgan stanleyNorges bankAcadia pharmaceuticals incEventide asset managementRoyal bankPharmaceuticals stock performancePharmaceuticals dailyMg investment management ltdPharmaceuticals incSecurities exchange commissionFred alger management

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesKimberly manhardJason butlerJoel beattyDavid hoangBrendan teehanElaine kimParag meswaniCarbidopa levodopa trxsKimberly manhartSteve davisTessa romeroJose loraAl kildaniGregory renzaMark schneyer

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLas vegasAcadia pharmaceuticalsBofa securities health care conferenceLife sciences conferenceAcadia pharmaceuticals incSciences conferenceMarkets global healthcare conference

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) CEO Stephen Davis Sells 11,427 Shares

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) CEO Stephen Davis sold 11,427 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $16.94, for a total transaction of $193,573.38. Following the transaction, the chief executive officer now owns 155,231 shares of the company’s […]

Sakhalinskaya oblastUnited statesRobertw bairdStephen davisPharmaceuticals price performancePharmaceuticals company profilePharmaceuticals dailyNorges bankEventide asset managementAcadia pharmaceuticals incPharmaceuticals incMg investment management ltdRoyal bankFred alger managementGet free reportAlger management

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) CEO Stephen Davis Sells 11,427 Shares of Stock

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) CEO Stephen Davis sold 11,427 shares of the business’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $16.94, for a total transaction of $193,573.38. Following the sale, the chief executive officer now directly owns 155,231 shares of the […]

United statesStephen davisPhocas financial corpEmpire life investments incRoyal bankPharmaceuticals incPharmaceuticals stock downPharmaceuticals company profileQuest partnersMorgan stanleyCantor fitzgeraldFranklin resources incAcadia pharmaceuticals incPharmaceuticals dailyGet free reportStock down